Access cutting-edge pulmonary hypertension treatment through this clinical trial at a research site in Stanford. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Stanford location
Access pulmonary hypertension specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pulmonary hypertension treatment provided free
Check if you qualify for this pulmonary hypertension clinical trial in Stanford, CA
No-Cost Study Care
Local to Stanford
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Researchers are looking for new ways to treat people with a type of pulmonary hypertension called combined postcapillary and precapillary pulmonary hypertension (Cpc-PH). This study focuses on Cpc-PH that is caused by heart failure with preserved ejection fraction (HFpEF). Researchers want to know if the study treatment, sotatercept, can treat people with Cpc-PH caused by HFpEF. This is an extension study, which means people who took part in a certain study on sotatercept for Cpc-PH (called a p
Sponsor: Merck Sharp & Dohme LLC
Yes, this clinical trial (NCT06814145) has an active research site in Stanford, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for pulmonary hypertension treatment options in Stanford, CA, this clinical trial (NCT06814145) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Stanford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pulmonary hypertension specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all pulmonary hypertension clinical trials near you to find additional studies recruiting in your area.
See all hypertension clinical trials recruiting in Stanford — not just this study.
Browse Hypertension Trials in Stanford →